DrugPatentWatch Database Preview
GLIADEL Drug Profile
or, see our see our flat-rate plans
Which patents cover Gliadel, and what generic alternatives are available?
The generic ingredient in GLIADEL is carmustine. There are ten drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the carmustine profile page.
Summary for GLIADEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 69 |
| Clinical Trials: | 37 |
| Patent Applications: | 7,132 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GLIADEL |
| DailyMed Link: | GLIADEL at DailyMed |
Pharmacology for GLIADEL
| Drug Class | Alkylating Drug |
| Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for GLIADEL
Synonyms for GLIADEL
| 1-(2-Chloroethyl)-1-([(2-chloroethyl)amino]carbonyl)-2-oxohydrazine # |
| 1,3-Bis(.beta.-chloroethyl)-1-nitrosourea |
| 1,3-bis(2-chloroethyl)-1-nitroso-urea |
| 1,3-Bis(2-chloroethyl)-1-nitrosourea |
| 1,3-bis(2-chloroethyl)-3-nitrosourea |
| 1,3-Bis(2-chloroethyl)nitrosourea |
| 1,3-Bis(beta-chloroethyl)-1-nitrosourea |
| 1,3-Bis(beta.-chloroethyl)-1-nitrosourea |
| 1,3-BIS(CHLOROETHYL)-1-NITROSOUREA |
| 1159711-15-5 |
| 1191292-23-5 |
| 13167-EP2270014A1 |
| 13167-EP2272827A1 |
| 13167-EP2272832A1 |
| 13167-EP2275420A1 |
| 13167-EP2277876A1 |
| 13167-EP2292614A1 |
| 13167-EP2295055A2 |
| 13167-EP2295416A2 |
| 13167-EP2295426A1 |
| 13167-EP2295427A1 |
| 13167-EP2298748A2 |
| 13167-EP2298764A1 |
| 13167-EP2298765A1 |
| 13167-EP2298768A1 |
| 13167-EP2298778A1 |
| 13167-EP2305642A2 |
| 13167-EP2308861A1 |
| 13167-EP2311453A1 |
| 13167-EP2311808A1 |
| 13167-EP2311825A1 |
| 13167-EP2311829A1 |
| 13167-EP2311842A2 |
| 13167-EP2314590A1 |
| 13167-EP2316832A1 |
| 13167-EP2316833A1 |
| 13167-EP2316834A1 |
| 13167-EP2374454A1 |
| 15164-EP2272827A1 |
| 15164-EP2316832A1 |
| 15164-EP2316833A1 |
| 154-93-8 |
| 154C938 |
| 4CA-0349 |
| A809590 |
| AB00052431_08 |
| AB00052431-07 |
| AB0011283 |
| AB2000140 |
| ABP000292 |
| AC-24196 |
| AC1L1DZQ |
| AI3-52216 |
| AK-51731 |
| AKOS005558013 |
| AN-1123 |
| ANW-61236 |
| AOB6824 |
| AS-12106 |
| BCNU |
| BCNU [Chloroethyl nitrosoureas] |
| BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea |
| BCP9000490 |
| BDBM50015950 |
| Becenum |
| Becenun |
| Bi CNU |
| BiCNU |
| BiCNU (TN) |
| Bio-0118 |
| Bis-N,N'-(chloroethyl)nitrosourea |
| Bis(2-chloroethyl)1-nitrosourea |
| Bis(2-chloroethyl)nitrosourea |
| Bis(chloroethyl)nitrosourea |
| Bischlorethylnitrosourea |
| Bischlorethylnitrosurea |
| Bischloroethyl nitrosourea |
| Bischloroethyl nitrosourea [Chloroethyl nitrosoureas] |
| Bischloroethylnitrosourea |
| BRN 2049744 |
| C 0400 |
| C06873 |
| C5H11Cl2N3O2 |
| C5H9Cl2N3O2 |
| Carmubris |
| Carmustin |
| Carmustina |
| Carmustina [INN-Spanish] |
| carmustine |
| Carmustine (JAN/USAN/INN) |
| Carmustine (USAN/INN) |
| Carmustine [USAN:INN:BAN] |
| Carmustine [USAN:USP:INN:BAN] |
| carmustine in ethanol |
| Carmustine, >=98% |
| Carmustine, United States Pharmacopeia (USP) Reference Standard |
| Carmustine(BiCNU)/ |
| Carmustinum |
| Carmustinum [INN-Latin] |
| Carustine |
| CAS-154-93-8 |
| CCG-39925 |
| CCRIS 810 |
| CHEBI:3423 |
| CHEMBL513 |
| CS-2935 |
| CTK8B8775 |
| D00254 |
| D0S9UT |
| DB00262 |
| DivK1c_000835 |
| DLGOEMSEDOSKAD-UHFFFAOYSA-N |
| DR000384 |
| DSSTox_CID_2743 |
| DSSTox_GSID_22743 |
| DSSTox_RID_76712 |
| DTI 015 |
| DTXSID8022743 |
| EINECS 205-838-2 |
| EU-0100188 |
| FDA 0345 |
| FIVB |
| FT-0083563 |
| FT-0602937 |
| Gliadel (MGI Pharm) |
| Gliadel (TN) |
| Gliadel Wafer |
| Gliadel, BCNU, NSC-409962, Becenun, Carmustine |
| Gliadel;BCNU;NSC-409962;Becenun;BiCNU |
| GTPL6800 |
| HMS2092J22 |
| HMS2230I05 |
| HMS3260F17 |
| HMS3369D17 |
| HMS502J17 |
| HSDB 7761 |
| HY-13585 |
| I14-11976 |
| IDI1_000835 |
| KB-216399 |
| KBio1_000835 |
| KBio2_000745 |
| KBio2_003313 |
| KBio2_005881 |
| KBioGR_001296 |
| KBioSS_000745 |
| Lopac-C-0400 |
| Lopac0_000188 |
| LP00188 |
| LS-890 |
| MCULE-3131772074 |
| MFCD00057706 |
| MLS001333962 |
| MolPort-003-665-505 |
| N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA |
| N,N''-Bis(2-chloroethyl)-N-nitrosourea |
| NCGC00015204-01 |
| NCGC00015204-02 |
| NCGC00015204-03 |
| NCGC00015204-04 |
| NCGC00015204-05 |
| NCGC00015204-06 |
| NCGC00015204-07 |
| NCGC00015204-08 |
| NCGC00015204-09 |
| NCGC00093665-01 |
| NCGC00093665-02 |
| NCGC00093665-03 |
| NCGC00093665-04 |
| NCGC00260873-01 |
| NCI-C04773 |
| NCI60_003931 |
| NINDS_000835 |
| Nitrumon |
| NSC 409962 |
| NSC-409962 |
| NSC-758392 |
| NSC409962 |
| NSC758392 |
| OR225495 |
| Pharmakon1600-01503110 |
| Prestwick_997 |
| SBI-0050176.P003 |
| SC-17305 |
| SCHEMBL4503 |
| SK 27702 |
| SMR000058426 |
| Spectrum_000265 |
| Spectrum4_000888 |
| Spectrum5_000920 |
| SR-01000075736 |
| SR-01000075736-1 |
| SRI 1720 |
| ST24036755 |
| STK624770 |
| TC-149981 |
| Tox21_110097 |
| Tox21_110097_1 |
| Tox21_500188 |
| U68WG3173Y |
| UNII-U68WG3173Y |
| Urea, 1,3-bis(2-chloroethyl)-1-nitroso- |
| Urea, N,N'-bis(2-chloroethyl)-N-nitroso- |
| Urea,3-bis(2-chloroethyl)-1-nitroso- |
| Urea,N'-bis(2-chloroethyl)-N-nitroso- |
| W-108025 |
| WLN: ONN2GVM2G |
| Z1563145982 |
| ZINC3830387 |
US Patents and Regulatory Information for GLIADEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
Expired US Patents for GLIADEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
or, see our see our flat-rate plans
